Veracyte | VCYT - 普通股股本

金融业

USD

USD 1.41B

现金及等价物

USD 362.58M

USD 39.29M

USD 488.38M

USD 59.94M

USD 40.45M

USD 24.63M

USD 42.31M

824

EPS每股收益

USD 0.53

股本和储备

USD 1.26B

USD 101.97M

债务利息支出

USD 2K

USD 3.48M

USD 0

USD 2.5B

USD 41.15M

USD 116.01M

USD 24.63M

普通股股本

USD 79.05M

45.3

USD 40.63M

USD 140.6M

销售和管理费用

USD 43.31M

USD 20.55M

贸易债权人

USD 4.59M

应收帐款人

USD 44.66M

	普通股股本	更改		日
Agenus	USD 35.32M		2.51M	2025-12
Agilent	USD 282.7M		358K	2025-12
Anika Therapeutics	USD 13.89M		532K	2025-12
Arrowhead Research	USD 135.7M		2.44M	2025-09
Bruker	USD 151.94M		225K	2025-12
Exact Sciences	USD 189.45M		232K	2025-09
Heron Therapeutics	USD 188.31M		4.99M	2025-12
Illumina	USD 152.8M		900K	2025-12
Intrexon	USD 0		0	2024-06
Karyopharm Therapeutics	USD 13K		0	2024-09
Laboratory Of America	USD 82.2M		700K	2025-12
Ligand Pharmaceuticals	USD 19.66M		19.64M	2025-09
Myriad Genetics	USD 93.5M		400K	2025-12
Rigel Pharmaceuticals	USD 17K		158K	2024-06
Roche Holding	CHF 795.62M		699.54K	2025-12
Siemens	EUR 780.74M		6.33M	2025-12
Sonic Healthcare	AUD 4.15B		467K	2024-12
Thermo Fisher Scientific	USD 375.71M		1.9M	2025-12
Veracyte	USD 79.05M		377K	2025-12
Waters	USD 98.08M		38.55M	2025-12